Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Laser light shows promise for thinning hair in new trial

NCT ID NCT07588243

Disease control Sponsor: CynosureLutronic Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 03, 2026 · Updated 2 times

Summary

This study is testing a device called Ultra that uses low-level laser light to help hair grow back. It involves 44 adults aged 22 to 70 with male or female pattern baldness. Participants will receive six laser treatments on their scalp, two weeks apart, and researchers will check if hair density and thickness improve after 90 days.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Low-level laser therapy device (Ultra)
What this could lead to
If successful, this could offer a non-invasive option to improve hair density and thickness for people with common hair loss.
What could go wrong
This is a small early study with only 44 participants, so results may not apply to everyone. The treatment requires multiple sessions and may not work for all types of hair loss.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 44 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

22 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 22 - 70 years old * Is willing to undergo study device use. * Fitzpatrick skin type I-VI * Clinical diagnosis of androgenetic alopecia (Norwood-Hamilton II-V or Ludwig I-II) * Willing to avoid significant changes to hair (such as drastic haircuts and dying hair) during their involvement in the study. * Willing to maintain current diet and exercise routine throughout study duration. * Understands and accepts the study condition to not receive any other procedures to the treatment area or to undergo any procedures, take any medications, supplements, or partake in any other treatments indicated for hair growth throughout the length of the study. * Understands and accepts the study condition of and agrees that he or she is able to be present for all study visits. * Willing to comply with all requirements of the study and is able to provide written informed consent. Exclusion Criteria: * Is female and pregnant, has been pregnant within the last 3 months, is currently breast feeding, or planning a pregnancy during the study period. * Has a diagnosis of other forms of alopecia (e.g., scarring alopecia, alopecia areata) * Has recent use (within 6 months) of a systemic hair growth medications (e.g., oral finasteride). * Inconsistent use of vitamins that can affect hair growth - must have stabilized use for at least 6 months prior to first treatment. * Had previous treatment (such as laser or topical) to scalp within 6 months. * Has a malignant disease, cancer, or uncontrolled medical condition. * Has an impaired immune system due to immunosuppressive diseases, such as AIDS and HIV, or use of immunosuppressive medications

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Androgenic alopecia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

alopecia androgenetic alopecia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Androgenic alopecia

Contacts and locations

Locations

  • Cynosure Lutronic

    Westford, Massachusetts, 01886, United States

  • Dy Dermatology

    Glenview, Illinois, 60025, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.